Journal Home > Volume 10 , Issue 3

This study was designed to elucidate the immunoregulation of Ganoderma lucidum. HPLC fingerprint and spectrum-effect relationship of G. lucidum were established to predict the active compounds and BP neural network model was established to predict the efficacy. Then the target compounds were identified by high resolution mass spectrometry. The results indicated that there are both enhanced immunity and immunosuppressive components in G. lucidum. BP neural network was trained with the common peak area and immune efficacy index of G. lucidum fingerprint as samples, and a combined evaluation system of G. lucidum fingerprint efficacy was established. The correlation coefficient R of BP network model was 0.986 43, and the error of pharmacodynamic prediction results was in the ideal range. Eight compounds were identified by high resolution mass spectrometry. The compounds related to immune activity in G. lucidum were determined in this study.


menu
Abstract
Full text
Outline
About this article

Spectrum-effect relationship of immunologic activity of Ganoderma lucidum by UPLC-MS/MS and component knock-out method

Show Author's information Changqin Lia,b,c,1Yiping Cuia,b,1Jie LuaLijun MengaChangyang Maa,b,cZhenhua Liua,b,c( )Yan Zhangd( )Wenyi Kanga,b,c( )
National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng 475004, China
Functional Food Engineering Technology Research Center, Henan Province, Kaifeng, 475004, China
Joint International Research Laboratory of Food & Medicine Resource Function, Henan Province, Henan University, Kaifeng 475004, China
Hebei Food Inspection and Research Institute, Shijiazhuang 050091, China

1 These authors contributed equally to this work.

Peer review under responsibility of KeAi Communications Co., Ltd

Abstract

This study was designed to elucidate the immunoregulation of Ganoderma lucidum. HPLC fingerprint and spectrum-effect relationship of G. lucidum were established to predict the active compounds and BP neural network model was established to predict the efficacy. Then the target compounds were identified by high resolution mass spectrometry. The results indicated that there are both enhanced immunity and immunosuppressive components in G. lucidum. BP neural network was trained with the common peak area and immune efficacy index of G. lucidum fingerprint as samples, and a combined evaluation system of G. lucidum fingerprint efficacy was established. The correlation coefficient R of BP network model was 0.986 43, and the error of pharmacodynamic prediction results was in the ideal range. Eight compounds were identified by high resolution mass spectrometry. The compounds related to immune activity in G. lucidum were determined in this study.

Keywords: Ganoderma lucidum, RAW 264.7 cell, Spectrum-effect relationships, Component knock-out, BP neural network

References(44)

[1]

C.R. Soccol, L.Y. Bissoqui, C. Rodrigues, et al., Pharmacological properties of biocompounds from spores of the lingzhi or reishi medicinal mushroom ganoderma lucidum (agaricomycetes): a review, Int. J. Med. Mushrooms 18 (2016) 757-767. https://doi.org/10.1615/IntJMedMushrooms.v18.i9.10

[2]

C.R. Cheng, J. Ding, Y. Yang, et al., Pharmacokinetic studies of ganoderic acids from the lingzhi or reishi medicinal mushroom, ganoderma lucidum (agaricomycetes), by LC-MS/MS, Int. J. Med. Mushrooms 18 (2016) 405-412. https://doi.org/10.1615/intjmedmushrooms.v18.i5.40

[3]

L.F. Wang, W.Y. Liang, W.J. Chen, et al., Screening and analysis of the marker components in G. lucidum by HPLC and HPLC-MSN with the aid of chemometrics, Molecules 22 (2017) 584. https://doi.org/10.3390/molecules22040584

[4]

M. Yang, X.M. Wang, S.H. Guan, et al., Analysis of triterpenoids in G. lucidumusing liquid chromatography coupled with electrospray ionization mass spectrometry, J. Am. Soc. Mass Spectrom. 18 (2007) 927-939. https://doi.org/10.1016/j.jasms.2007.01.012

[5]

P.Z. Li, K.C. Zhang, Isolation, purification, and antimicrobial activity of ganoderic acids M1 from the fermented mycelia of Ganoderma lucidum, Nat. Prod. Res. 11 (1999) 67-70. https://doi.org/10.16333/j.1001-6880.1999.04.014

[6]

B. Bo, G. lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs, Recent Pat. Anticancer. Drug. Discov. 8 (2013) 255-287. https://doi.org/10.2174/1574891X113089990036

[7]

L. Feng, L. Yuan, Y. Du, et al., Anti-lung cancer activity through enhancement of immunomodulation and induction of cell apoptosis of total triterpenes extracted from Ganoderma luncidum (Leyss. ex Fr. ) Karst, Molecules 18 (2013) 9966-9981. https://doi.org/10.3390/molecules18089966

[8]

T.P. Smina, J. Mathew, K.K. Janardhanan, et al., Antioxidant activity and toxicity profile of total triterpenes isolated from G. lucidum (Fr. ) P. Karst occurring in South India, Environ. Toxicol. Pharmacol. 32 (2011) 438-446. https://doi.org/10.1016/j.etap.2011.08.011

[9]

Q. Xia, H.Z. Zhang, X.F. Sun, et al., A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp, Molecules 19 (2014) 17478-17535. https://doi.org/10.3390/molecules191117478

[10]

F.F.Y. Radwan, A. Hossain, J.M. God, et al., Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid, J. Cell. Biochem. 116 (2015) 102-114. https://doi.org/10.1002/jcb.24946

[11]

S.M. Huang, X.L. Yang, B.W. Wang, et al., Antitumor activity of ethanol-soluble and acidic components from G. lucidum, Nat. Prod. Res. 16 (2004) 146-148. https://doi.org/10.16333/j.1001-6880.2004.02.015

[12]

Y.J. Liu, J.L. Du, L.P. Cao, et al., Anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides on carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio L. ), Int. Immunopharmacol. 1 (2015) 112-120. https://doi.org/10.1016/j.intimp.2015.01.023

[13]

Y.J. Kan, T.Q. Chen, Y.B. Wu, et al., Antioxidant activity of polysaccharide extracted from Ganoderma lucidum using response surface methodology, Int. J. Biol. Macromol. 10 (2015) 943-955. https://doi.org/10.1016/j.ijbiomac.2014.07.056

[14]

M. Shi, Z.Y. Zhang, Y.N. Yang, Antioxidant and immunoregulatory activity of G. lucidum polysaccharide (GLP), Carbohydr. Polym. 1 (2013) 200-206. https://doi.org/10.1016/j.carbpol.2013.02.081

[15]

S. Fatmawati, R. Kondo, K. Shimizu, ChemInform abstract: structure–activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 23 (2013) 5900-5903. https://doi.org/10.1002/chin.201411205

[16]

Y.Z. Xie, S.Z. Li, A. Yee, et al., G. lucidum inhibits tumour cell proliferation and induces tumour cell death, Enzyme. Microb. Technol 40 (2006) 177-185. https://doi.org/10.1016/j.enzmictec.2005.10.051

[17]

G.Q. Liu, K.C. Zhang, Mechanisms of the anticancer action of G. lucidum (Leyss. ex Fr. ) Karst. : a new understanding, J. Integr. Plant. Biol. 47 (2005) 129-135. https://doi.org/10.1111/j.1744-7909.2005.00037.x

[18]

A. Bhardwaj, M. Srivastava, M. Pal, et al., Screening of Indian lingzhi or reishi medicinal mushroom, G. lucidum (agaricomycetes): a UPC2-SQD-MS approach, Int. J. Med. Mushrooms. 18 (2016) 177-189. https://doi.org/10.1111/j.1744-7909.2005.00037.x

[19]

S. Yamin, M. Shuhaimi, A. Arbakariya, et al., Effect of G. lucidum polysaccharides on the growth of Bifidobacterium spp. as assessed using real-time PCR, Food. Res. Int. 19 (2012) 1199-1205

[20]

B. Yurkiv, S.P. Wasser, E. Nevo, et al., The effect of Agaricus brasiliensis and G. lucidum medicinal mushroom administration on the L-arginine/nitric oxide system and rat leukocyte apoptosis in experimental type 1 diabetes mellitus, Int. J. Med. Mushrooms. 17 (2015) 339-350. https://doi.org/10.1615/intjmedmushrooms.v17.i4.30

[21]

N.M. Delzenne, L.B. Bindels, Gut microbiota: G. lucidum, a new prebiotic agent to treat obesity?, Nat. Rev. Gastroenterol. Hepatol. 12 (2015) 553-554. https://doi.org/10.1038/nrgastro.2015.137

[22]

I.C.F.R. Ferreira, J.A. Vaz, M.H. Vasconcelos, et al., Compounds from wild mushrooms with antitumor potential, Anticancer. Agents. Med. Chem. 10 (2010) 424-436. https://doi.org/10.2174/1871520611009050424

[23]

R.R.M. Paterson, Ganoderma-a therapeutic fungal biofactory, Phytochemistry. 67 (2006) 1985-2001. https://doi.org/10.1016/j.phytochem.2006.07.004

[24]

C. Murata, Q.T. Tran, S. Onda, et al., Extraction and isolation of ganoderic acid Σ from G. lucidum, Tetrahedr. Lett. 57 (2016) 5368-5371. https://doi.org/10.1016/j.tetlet.2016.10.072

[25]

Y. Mizushina, N. Takahashi, L. Hanashima, et al., Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, G. lucidum, Bioorg. Med. Chem. 7 (1999) 2047-2052. https://doi.org/10.1016/S0968-0896(99)00121-2

[26]

Z.Z. Zhao, R.H. Yin, H.P. Chen, et al., Two new triterpenoids from fruiting bodies of fungus G. lucidum, J. Asian Nat. Prod. Res. 17 (2015) 1-6. https://doi.org/10.1080/10286020.2014.996139

[27]

D.Z. Liu, Y.Q. Zhu, X.F. Li, et al., New triterpenoids from the fruiting Bodies of G. lucidum and their bioactivities, Chem. Biodivers. 6 (2014) 982-986. https://doi.org/10.1002/cbdv.201400004

[28]

Y.B. Li, R.M. Liu, J.J. Zhong, A new ganoderic acid from G. lucidum mycelia and its stability, Fitoterapia. 83 (2013) 115-122. https://doi.org/10.1016/j.fitote.2012.11.008

[29]

Y. Liu, Y.L. Xu, L. Li, Relationships between the spectrum of traditional Chinese medicine research and application, Lishizhen. Med. Mater. Med. Re. 29 (2018) 677-680

[30]

X.Y. Zhang, J.S. Liu, S.M. Gao, et al., Research methods and applications progress on spectrum-effect relationships in study of traditional Chinese medicine, China. J. Chin. Mater. Med. 44 (2019) 4405-4411. https://doi.org/10.19540/j.cnki.cjcmm.20190429.201

[31]

S. Belkacem, S. Bouafia, M. Chabani, Study of oxytetracycline degradation by means of anodic oxidation process using platinized titanium (Ti/Pt) anode and modeling by artificial neural networks, Process. Saf. Environ. Prot. 111 (2017) 170-179. https://doi.org/10.1016/j.psep.2017.07.007

[32]

Y.Q. Han, Y. Cao, Y.N. Dong, et al., Spectrum-effect relationship of wind-dispersing and exterior syndrome-relieving of Shufeng Jiedu Capsules, Zhong Cao Yao 50 (2019) 3534-3540. https://doi.org/10.1016/j.psep.2017.07.007

[33]

J. Zhou, L. Qi, P. Li, Quality control of Chinese herbal medicines with chromatographic fingerprints, Chin. J. Chromatogr. 26 (2008) 153-159. https://doi.org/10.7501/j.issn.0253-2670.2019.15.003

[34]

R.Y. Xiao, P.P. Teng, C. Hu, et al., Research progress in application of partial least squares regression analysis in the spectrum-effect, Liaoning Chemical Industry 49 (2020) 303-305. https://doi.org/10.14029/j.cnki.issn1004-0935.2020.03.026

[35]

L. Zhang, J. Yan, X. Liu, et al., Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective, J. Ethnopharmacol. 140 (2012) 519. https://doi.org/10.1016/j.jep.2012.01.058

[36]

S.J. Lee, K.T. Lim, Phytoglycoprotein inhibits interleukin-1beta and interleukin-6 via p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated RAW 264.7 cells, Naunyn Schmiedebergs Arch Pharmacol 377 (2008) 45-54. https://doi.org/10.1007/s00210-007-0253-8

[37]

X.P. Zhao, X.H. Fan, J. Yu, et al., A method for predicting activity of traditional Chinese medicine based on quantitative composition-activity relationship of neural network model, China J. Chin. Mater. Med. 29 (2004) 1082. https://doi.org/10.1007/s10354-004-0117-5

[38]

C.E. Alciaturi, M.E. Escobar, C.D.L. Cruz, et al., Partial least squares (PLS) regression and its application to coal analysis, Revista Técnica de la Facultad de Ingeniería Universidad del Zulia. 26 (2003) 197-204

[39]

T.J. Li, S. Wang, X.S. Meng, et al., Study on spectrum-effect relationship of Qi-Zhi Wei-Tong granules treated for gastric ulcer, Modernization. Tradit. Chin. Med. Mater. Medica-World. Sci. Technol. 17 (2015) 103-108

[40]

F. Wang, Z.Y. Xiong, P. Li, et al., From chemical consistency to effective consistency in precise quali, J. Pharm. Biomed. Anal. 132 (2017) 7-16. https://doi.org/10.1016/j.jpba.2016.09.042

[41]

Y.L. Liu, Y.P. Liu, F. Qiu, Sensitive and selective liquid chromatography–tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species, J. Parm. Biomed. Anal. 54 (2011) 717-721. https://doi.org/10.1016/j.jpba.2010.11.002

[42]

Z.M. Qian, Z. Jing, D.Q. Li, et al., Analysis of global components in Ganoderma using liquid chromatography system with multiple columns and detectors, J. Sep. Sci. 35 (2012) 2725-2734. https://doi.org/10.1002/jssc.201200441

[43]

H.J. Xin, L.L. Fang, J.B. Xie, et al., Identification and quantification of triterpenoids in Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (agaricomycetes), with HPLC-MS/MS methods, Int. J. Med Mushrooms 10 (2018) 919-934. https://doi.org/10.1615/IntJMedMushrooms.2018027398

[44]

X.Y. Guo, X. Shen, J. Long, et al., Structural identification of the metabolites of ganoderic acid B from Ganoderma lucidum in rats based on liquid chromatography coupled with electrospray ionization hybrid ion trap and time-of-flight mass spectrometry, Biomed Chromatogr. 27 (2013) 1177-1187. https://doi.org/10.1002/bmc.2924

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 07 June 2020
Revised: 19 August 2020
Accepted: 21 September 2020
Published: 16 April 2021
Issue date: May 2021

Copyright

© 2021 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Acknowledgements

This work was funded by the National Key R & D Program of China (2018YFD0400200), Key Project in Science and Technology Agency of Kaifeng City (1906006), Major Public Welfare Projects in Henan Province (201300110200).

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return